CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF MEDICAL OFFICER sold 400 shares at $17.53 ($7,012)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 29,000 shares at an average $19.14 ($555,160)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Grant or award Director acquired 17,492 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 21 of 39 · 778 filings